Delivery Order SPE2DB20D1100-SPE2DB25FD9R8
- Not listed
- The Defense Logistics Agency awarded a $27,345.32 delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a non-set-aside competitive procurement and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,842.20 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 18, 2025, with completion expected by September 19, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, representing a...
- The Defense Logistics Agency awarded a delivery order valued at $8,917.36 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on July 25, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention,...
- The Defense Logistics Agency awarded a delivery order valued at $15,530.23 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 16, 2025, with a completion date of September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $30,140.34 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 20, 2025, with an ultimate completion date of August 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment,...
- The Defense Logistics Agency awarded a delivery order valued at $5,577.61 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) with an ultimate completion date of July 28, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting the federal government's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,984.88 for DESCOVY 200-25 mg tablets (30-count units) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV prevention and treatment, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 units, valued at $8,697.19 under a firm fixed price arrangement. This non-set-aside delivery order, issued on August 12, 2025, with completion scheduled for August 13, 2025, will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV prevention and treatment, reflecting the federal...
- The Defense Logistics Agency awarded a delivery order valued at $5,795.72 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets in quantities of 30 on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. DESCOVY is an HIV treatment medication combining emtricitabine and tenofovir alafenamide,...
- The Defense Logistics Agency awarded a delivery order valued at $65,557.87 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on September 10, 2025, with completion scheduled for September 11, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used for HIV treatment and prevention, supporting the federal government's...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FD9R8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,900.78 to AmerisourceBergen Drug Corp for DESCOVY 200-25 mg tablets (30-count units) on August 8, 2025, with a completion date of August 11, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. DESCOVY is an antiretroviral medication used in HIV treatment and prevention, reflecting the Department of Defense's ongoing pharmaceutical supply requirements for military healthcare systems. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally, including support for the Defense Health Agency and U.S. Coast Guard. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen maintains an extensive portfolio of delivery orders across multiple therapeutic domains, demonstrating its capability to fulfill diverse federal healthcare supply needs through competitive procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.9k | 8/8/25 |